ETF PRO AINovember 17, 2026
XBI SPDR S&P Biotech ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.35%expense ratio
$10.3Bfund assets
+19.6%return, YTD
—return, 1 year
−$8Mnet flow, 1 month
+$675Mnet flow, 1 year
30.3%realized volatility, 1y
-14.9%worst drawdown, 1y
Top ten holdings
| 1 | MRNA MODERNA | 2.47% |
| 2 | BIIB BIOGEN | 1.80% |
| 3 | AMGN AMGEN | 1.79% |
| 4 | REGN REGENERON PHARMACEUTICALS | 1.78% |
| 5 | ABBV ABBVIE | 1.76% |
| 6 | UTHR UNITED THERAPEUTICS | 1.75% |
| 7 | GILD GILEAD SCIENCES | 1.74% |
| 8 | EXEL EXELIXIS | 1.78% |
| 9 | TGTX TG THERAPEUTICS | 1.77% |
| 10 | SYRE SPYRE THERAPEUTICS INC | 1.80% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS